Connect Biopharma Holdings Limited
25.10%
13,950,000
1835268
207523101
Jul 20, 2025
Jul 21, 2025, 09:00 AM
Reporting Persons (4)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Panacea Innovation Limited | CO | 25.10% | 13,950,000 | 0 | 13,950,000 |
| Panacea Venture Healthcare Fund II, L.P. | Partnership | 25.10% | 13,950,000 | 0 | 13,950,000 |
| Panacea Venture Healthcare Fund II GP Company, Ltd. | CO | 25.10% | 13,950,000 | 0 | 13,950,000 |
| James Huang | Individual | 25.10% | 13,950,000 | 0 | 13,950,000 |
Disclosure Items (3)
Ordinary Shares
Connect Biopharma Holdings Limited
3580 Carmel Mountain Road, San Diego, CA, 92130
Item 3 of the Schedule 13D is hereby amended and supplemented as follows: Since July 1, 2024, Panacea Venture Healthcare Fund II, L.P. has purchased 540,000 American Depositary Shares (each representing one Ordinary Share) in a series of open market transactions at a weighted average price of $1.3621 per American Depositary Share. Panacea Venture Healthcare Fund II, L.P. obtained the funds used to purchase the Ordinary Shares through capital contributions from its partners.
Item 5 of the Schedule 13D is hereby amended and restated in its entirety as follows: The information contained on the cover pages to this Schedule 13D is incorporated by reference into this Item 5. The ownership information presented herein represents beneficial ownership of Ordinary Shares as of the date of this filing, based upon 55,561,056 Ordinary Shares outstanding as of April 30, 2025, as disclosed in the Issuer's Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on May 15, 2025. Panacea Venture Healthcare Fund II, L.P. is the record holder of the Ordinary Shares reported herein. James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd., which is the general partner of Panacea Venture Healthcare Fund II, L.P. As a result, each of the Reporting Persons may be deemed to share beneficial ownership of the Ordinary Shares directly reported herein, but each disclaims such beneficial ownership.
The information contained on the cover pages to this Schedule 13D is incorporated by reference into this Item 5.
During the past 60 days, Panacea Venture Healthcare Fund II, L.P. purchased 170,000 American Depositary Shares (each representing one Ordinary Share) in open market transactions on the Nasdaq Global Market. Details by date, listing the number of American Depositary Shares acquired and the weighted average price per share for transactions that were effected during the past sixty days are provided below. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price for this transaction. July 11, 2025 25,000 American Depositary Shares acquired $1.3615 Weighted Average Price per Share July 14, 2025 20,000 American Depositary Shares acquired $1.4069 Weighted Average Price per Share July 17, 2025 125,000 American Depositary Shares acquired $1.7201 Weighted Average Price per Share
None
Not applicable.